Aphios awarded $2.4M to develop Alzheimer's treatment

It also works on a platform for drug development, nanotechnology drug delivery and pathogenic drug safety. To treat Alzheimer's, Aphios has developed APH-0703, a potent protein kinase C modulator. The company is working with Lousiana State University ...

Aphios awarded $2.4M to develop Alzheimer's treatment

Votes: 0
E-mail me when people leave their comments –

You need to be a member of The International NanoScience Community - Nanopaprika.eu to add comments!

Join The International NanoScience Community - Nanopaprika.eu